The Endometrial Cancer Market Report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period on the basis of the market’s historical growth trajectory and figures.
GET FREE SAMPLE COPY FOR FUTURE ADVANCEMENT @
https://www.marketresearchfuture.com/sample_request/6226
Leading Market Players
Pfizer Inc., General Electric Company, Koninklijke Philips N.V., LUPIN, PHYTON, Bayer AG, Celgene Corporation, Johnson & Johnson, CooperSurgical Inc., LiNA Medical USA, Conceptus Inc., Hologic Inc., Karl Storz GmbH & Co. Kg, and Boston Scientific Corporation.
Endometrial Cancer Market Analysis
Endometrial cancer, also known as uterine cancer, is defined as an abnormal growth of endometrium cells in the uterus. Market Research Future (MRFR) has published a research report about the global endometrial cancer market that estimates robust growth for this market between 2018 and 2023. The key factors driving this market are changes in sedentary lifestyle, growing consumption of unhealthy diet, growing obesity among women, increase in menopausal hormone therapy, increasing occurrence of Polycystic Ovarian Syndrome (PCOS), increasing prevalence of breast or ovarian tumor, rising prevalence of endometrial cancer, and various socioeconomic factors.
Segmentation:
By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy. Endometrial biopsy is very common as the confirmatory test for uterine cancer.
Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. The hysterectomy techniques category comprises open abdominal hysterectomy, total vaginal hysterectomy, total laparoscopic hysterectomy, and robotic hysterectomy. External radiation and internal radiation (brachytherapy) are part of radiation technology. The hormonal therapy consists progestins, tamoxifen, luteinizing hormone-releasing hormone agonists, and aromatase inhibitors. Chemotherapy can be further sub-segmented into paclitaxel, carboplatin, doxorubicin, and cisplatin and is also the most-used treatment method.
Based on the end-users the market can be segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.
Table of Content
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Continued…
Browse Complete 100 Pages Premium Research Report @
https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226
Latest Industrial News
• Leaders from UT Health San Antonio and MD Anderson Cancer Center have discussed the partnership between the institutions for cancer research and treatment and its benefit to local cancer patients. 5 SEP 2018
• The FDA has granted a breakthrough therapy designation to the combination of lenvatinib (Lenvima) and pembrolizumab (Keytruda). This therapy is useful for the treatment of patients with advanced and/or metastatic non–microsatellite instability-high (MSI-H)/proficient mismatch repair endometrial carcinoma. However, only those who have progressed after more than 1 prior systemic therapy are eligible for this treatment. 1 AUG 2018
Related News
Orthodontic Supplies Market Research Report – Forecast to 2023
Needle Free Injection Market Research Report –Global Forecast to 2023
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226